09 May 07 Ranbaxy acquires Be-Tabs Pharma

Ranbaxy Laboratories informed the Indian Stock Exchanges that, on May 08, 2007, it received an approval from South Africa’s Competition Commission to acquire Be-Tabs Pharmaceuticals. The Be Tabs pharmaceuticals acquisition is valued at Rs. 50 crores and it would enable Ranbaxy Laboratories to become the fifth largest generic pharmaceutical company in South Africa.

Related Posts

Ranbaxy Open Offer Details

Bafna Pharma IPO Allotment Status

Ranbaxy gets FDA approval and a 180 day monopoly for pravastatin sodium drug

Sun Pharma to acquire Israel’s Taro Pharmaceutical Industries

Ammana Bio Pharma Limited Undersubscribed on closing day

Ranbaxy fixes Zenotech Laboratories Open Offer Price

GMR Infrastructure acquires GMR Aviation

3i Infotech acquires 26% stake in taxsmile.com

Bharati Shipyard acquires Shipyard machinery and equipments of Swan Hunter

DLF acquires West Delhi Land from DCM Shriram Consolidated (DSCL)

BAFNA Pharma IPO Subscription Date

Glenmark Pharmaceuticals Stock Split

IVRCL Infrastructure acquires Alkor Petroo

Abbott India share Buy Back offer approved

Fortis Healthcare – Valuations Expensive but Listing gains expected

Leave a Comment

Name (required)

Mail (will not be published) (required)